Dynamic aberrant NF-κB spurs tumorigenesis: a new model encompassing the microenvironment.

Recently it was discovered that a transient activation of transcription factor NF-κB can give cells properties essential for invasiveness and cancer initiating potential. In contrast, most oncogenes to date were characterized on the basis of mutations or by their constitutive overexpression. Study of NF-κB actually leads to a far more dynamic perspective on cancer: tumors caused by diverse oncogenes apparently evolve into cancer after loss of feedback regulation for NF-κB. This event alters the cellular phenotype and the expression of hormonal mediators, modifying signals between diverse cell types in a tissue. The result is a disruption of stem cell hierarchy in the tissue, and pervasive changes in the microenvironment and immune response to the malignant cells.

[1]  G. Hartmann,et al.  Therapeutic efficacy of bifunctional siRNA combining TGF-β1 silencing with RIG-I activation in pancreatic cancer. , 2013, Cancer research.

[2]  Ryan M. O’Connell,et al.  NF-κB dysregulation in microRNA-146a–deficient mice drives the development of myeloid malignancies , 2011, Proceedings of the National Academy of Sciences.

[3]  S. Badve,et al.  NF-κB represses E-cadherin expression and enhances epithelial to mesenchymal transition of mammary epithelial cells: potential involvement of ZEB-1 and ZEB-2 , 2007, Oncogene.

[4]  Eric A Bushong,et al.  Dedifferentiation of Neurons and Astrocytes by Oncogenes Can Induce Gliomas in Mice , 2012, Science.

[5]  A. Levine,et al.  The regulation of exosome secretion: a novel function of the p53 protein. , 2006, Cancer research.

[6]  E. Albi,et al.  Severe hypocholesterolaemia is often neglected in haematological malignancies. , 2010, European journal of cancer.

[7]  Mi-Ra Lee,et al.  Expression of CD133 in neuroendocrine neoplasms of the digestive tract: a detailed immunohistochemical analysis. , 2013, The Tohoku journal of experimental medicine.

[8]  B. Martín-Castillo,et al.  Metformin against TGFβ-induced epithelial-to-mesenchymal transition (EMT): From cancer stem cells to aging-associated fibrosis , 2010, Cell cycle.

[9]  Youming Xie.  Structure, assembly and homeostatic regulation of the 26S proteasome. , 2010, Journal of molecular cell biology.

[10]  S. Armstrong,et al.  Association of high-level MCL-1 expression with in vitro and in vivo prednisone resistance in MLL-rearranged infant acute lymphoblastic leukemia. , 2010, Blood.

[11]  F. Rodier,et al.  DDR-mediated crosstalk between DNA-damaged cells and their microenvironment , 2015, Front. Genet..

[12]  A. Mantovani,et al.  Pathomechanisms: homeostatic chemokines in health, tissue regeneration, and progressive diseases. , 2014, Trends in molecular medicine.

[13]  Joshua M. Korn,et al.  Pharmacological and genomic profiling identifies NF-κB–targeted treatment strategies for mantle cell lymphoma , 2013, Nature Medicine.

[14]  T. Okubo,et al.  Radiation and cancer risk in atomic-bomb survivors , 2012, Journal of radiological protection : official journal of the Society for Radiological Protection.

[15]  M. Toruner,et al.  Antianoikis Effect of Nuclear Factor-κB through Up-regulated Expression of Osteoprotegerin, BCL-2, and IAP-1* , 2006, Journal of Biological Chemistry.

[16]  J. Byrd,et al.  NF-κB Functions in Tumor Initiation by Suppressing the Surveillance of Both Innate and Adaptive Immune Cells , 2014, Cell reports.

[17]  S. Janz,et al.  NF-κB/STAT3/PI3K signaling crosstalk in iMycEμ B lymphoma , 2010, Molecular Cancer.

[18]  L. Staudt.  Oncogenic activation of NF-kappaB. , 2010, Cold Spring Harbor perspectives in biology.

[19]  J. Brady,et al.  A Novel NF-κB Pathway Involving IKKβ and p65/RelA Ser-536 Phosphorylation Results in p53 Inhibition in the Absence of NF-κB Transcriptional Activity* , 2005, Journal of Biological Chemistry.

[20]  Genhong Cheng,et al.  Non‐canonical NF‐κB signaling activation and regulation: principles and perspectives , 2011, Immunological reviews.

[21]  G. G. Stokes.  "J." , 1890, The New Yale Book of Quotations.

[22]  P. Dent,et al.  Disruption of IκB Kinase (IKK)-mediated RelA Serine 536 Phosphorylation Sensitizes Human Multiple Myeloma Cells to Histone Deacetylase (HDAC) Inhibitors* , 2011, The Journal of Biological Chemistry.

[23]  Xin-Yun Huang,et al.  A Signal Transducer and Activator of Transcription 3·Nuclear Factor κB (Stat3·NFκB) Complex Is Necessary for the Expression of Fascin in Metastatic Breast Cancer Cells in Response to Interleukin (IL)-6 and Tumor Necrosis Factor (TNF)-α* , 2014, The Journal of Biological Chemistry.

[24]  Q. Zhan,et al.  PLK 1 Is Transcriptionally Activated by NFk B during Cell Detachment and Enhances Anoikis Resistance through Inhibiting b-Catenin Degradation in Esophageal Squamous Cell Carcinoma , 2011 .

[25]  J. Fridman,et al.  INCB16562, a JAK1/2 selective inhibitor, is efficacious against multiple myeloma cells and reverses the protective effects of cytokine and stromal cell support. , 2010, Neoplasia.

[26]  Xin-Yuan Fu,et al.  Mouse hematopoietic cell-targeted STAT3 deletion: stem/progenitor cell defects, mitochondrial dysfunction, ROS overproduction, and a rapid aging-like phenotype. , 2012, Blood.

[27]  Fiona Ross,et al.  NKT cell activation by diverse antigens and antigen-presenting cells , 2013 .

[28]  Alexander Hoffmann,et al.  Generation and Activation of Multiple Dimeric Transcription Factors within the NF-κB Signaling System , 2008, Molecular and Cellular Biology.

[29]  S. Saccani,et al.  Modulation of NF-κB Activity by Exchange of Dimers , 2003 .

[30]  Wei-Yun Sheng,et al.  A major role of PKC θ and NFκB in the regulation of hTERT in human T lymphocytes , 2006 .

[31]  S. Liang,et al.  Resistance to experimental tumorigenesis in cells of a long‐lived mammal, the naked mole‐rat (Heterocephalus glaber) , 2010, Aging cell.

[32]  Yan Liu,et al.  An NF-κB pathway-mediated positive feedback loop amplifies Ras activity to pathological levels in mice. , 2012, The Journal of clinical investigation.

[33]  G. Reuther,et al.  JAK2‐V617F‐mediated signalling is dependent on lipid rafts and statins inhibit JAK2‐V617F‐dependent cell growth , 2013, British journal of haematology.

[34]  Michael Naumann,et al.  Dynamics of p53 and NF-κB regulation in response to DNA damage and identification of target proteins suitable for therapeutic intervention , 2012, BMC Systems Biology.

[35]  J. Drouin,et al.  Regulatory Network Analyses Reveal Genome-Wide Potentiation of LIF Signaling by Glucocorticoids and Define an Innate Cell Defense Response , 2008, PLoS genetics.

[36]  M. Karin,et al.  IκB kinase α kinase activity is required for self-renewal of ErbB2/Her2-transformed mammary tumor-initiating cells , 2007, Proceedings of the National Academy of Sciences.

[37]  B. Aggarwal,et al.  Characterization and mechanistic studies of a novel melanoma-targeting construct containing IκBa for specific inhibition of nuclear factor-κB activity. , 2010, Neoplasia.

[38]  A. Brasier,et al.  Tumor necrosis factor-alpha-inducible IkappaBalpha proteolysis mediated by cytosolic m-calpain. A mechanism parallel to the ubiquitin-proteasome pathway for nuclear factor-kappab activation. , 1999, The Journal of biological chemistry.

[39]  J. Abrahamsson,et al.  Interleukin 6, but not tumour necrosis factor‐α, is a good predictor of severe infection in febrile neutropenic and non‐neutropenic children with malignancy , 1997, Acta paediatrica.

[40]  J. Vadgama,et al.  Constitutive Activation of STAT3 Signaling Regulates hTERT and Promotes Stem Cell-Like Traits in Human Breast Cancer Cells , 2013, PloS one.

[41]  John B. Shoven,et al.  I , Edinburgh Medical and Surgical Journal.

[42]  G. Natoli.  NF‐κB and chromatin: ten years on the path from basic mechanisms to candidate drugs , 2012, Immunological reviews.

[43]  J. Gribben,et al.  Blocking Autophagy Prevents Bortezomib-Induced NF-κB Activation by Reducing I-κBα Degradation in Lymphoma Cells , 2012, PloS one.

[44]  L. Yang,et al.  Roles of tumor suppressors in regulating tumor-associated inflammation , 2014, Cell Death and Differentiation.

[45]  D. Son,et al.  Inhibitory Effect of Tumor Suppressor p53 on Proinflammatory Chemokine Expression in Ovarian Cancer Cells by Reducing Proteasomal Degradation of IκB , 2012, PloS one.

[46]  Q. Zhan,et al.  PLK1 Is Transcriptionally Activated by NF-κB during Cell Detachment and Enhances Anoikis Resistance through Inhibiting β-Catenin Degradation in Esophageal Squamous Cell Carcinoma , 2011, Clinical Cancer Research.

[47]  J. Copland,et al.  An Effective Personalized Approach to a Rare Tumor: Prolonged Survival in Metastatic Pancreatic Acinar Cell Carcinoma Based on Genetic Analysis and Cell Line Development , 2011, Journal of Cancer.

[48]  J. Kellum,et al.  Interleukin 6 , 1994, Critical care medicine.

[49]  F. Tzortzatou-Stathopoulou,et al.  Sex steroid receptors in skeletal differentiation and epithelial neoplasia: is tissue‐specific intervention possible? , 2009, BioEssays : news and reviews in molecular, cellular and developmental biology.

[50]  Kevin Struhl,et al.  An Epigenetic Switch Involving NF-κB, Lin28, Let-7 MicroRNA, and IL6 Links Inflammation to Cell Transformation , 2009, Cell.

[51]  K. Pienta,et al.  The Lethal Phenotype of Cancer: The Molecular Basis of Death Due to Malignancy , 2007, CA: a cancer journal for clinicians.

[52]  Li Ding,et al.  C11orf95-RELA fusions drive oncogenic NF-κB signaling in ependymoma , 2014, Nature.

[53]  J. McCubrey,et al.  AMP-dependent kinase/mammalian target of rapamycin complex 1 signaling in T-cell acute lymphoblastic leukemia: therapeutic implications , 2012, Leukemia.

[54]  G. Xiao,et al.  NF-κB and cancer: a paradigm of Yin-Yang. , 2011, American journal of cancer research.

[55]  A. Thotakura,et al.  The nuclear factor kappa B signaling pathway: integrating metabolism with inflammation. , 2012, Trends in cell biology.

[56]  G. Brandi,et al.  Antiprotease Strategy in Pancreatic Cancer Treatment: Emergence From a Preclinical Study , 2014, Pancreas.

[57]  Lin-Feng Chen,et al.  Posttranslational modifications of NF-kappaB: another layer of regulation for NF-kappaB signaling pathway. , 2010, Cellular signalling.

[58]  L. Zitvogel,et al.  Dendritic cells and innate defense against tumor cells. , 2008, Cytokine & growth factor reviews.

[59]  J. Reis-Filho,et al.  Progression from ductal carcinoma in situ to invasive breast cancer: Revisited , 2013, Molecular oncology.

[60]  D. Vocadlo,et al.  Hyper-O-GlcNAcylation Is Anti-apoptotic and Maintains Constitutive NF-κB Activity in Pancreatic Cancer Cells* , 2013, The Journal of Biological Chemistry.

[61]  Michael K. Wendt,et al.  Epithelial to Mesenchymal Transition Promotes Breast Cancer Progression via a Fibronectin-dependent STAT3 Signaling Pathway* , 2013, The Journal of Biological Chemistry.

[62]  M. Ebsen,et al.  Tumor‐associated macrophages exhibit pro‐ and anti‐inflammatory properties by which they impact on pancreatic tumorigenesis , 2014, International journal of cancer.

[63]  Li Yang,et al.  TGF-beta and immune cells: an important regulatory axis in the tumor microenvironment and progression. , 2010, Trends in immunology.

[64]  A. Strasser,et al.  The NF‐κB1 transcription factor prevents the intrathymic development of CD8 T cells with memory properties , 2012, The EMBO journal.

[65]  L. Staudt,et al.  Cooperative signaling through the signal transducer and activator of transcription 3 and nuclear factor-{kappa}B pathways in subtypes of diffuse large B-cell lymphoma. , 2008, Blood.

[66]  J. Lancaster,et al.  Fascin Protein Is Critical for Transforming Growth Factor β Protein-induced Invasion and Filopodia Formation in Spindle-shaped Tumor Cells* , 2011, The Journal of Biological Chemistry.

[67]  M. Russo,et al.  Overexpression of pro-inflammatory genes and down-regulation of SOCS-1 in human PTC and in hypoxic BCPAP cells. , 2013, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[68]  N. Perkins,et al.  p53-dependent regulation of mitochondrial energy production by the RelA subunit of NF-κB. , 2011, Cancer research.

[69]  Tzu-chien V. Wang,et al.  A major role of PKC theta and NFkappaB in the regulation of hTERT in human T lymphocytes. , 2006, FEBS letters.

[70]  A. Salminen,et al.  Emerging role of NF-κB signaling in the induction of senescence-associated secretory phenotype (SASP). , 2012, Cellular signalling.

[71]  Andreas Trumpp,et al.  The evolving concept of cancer and metastasis stem cells , 2012, The Journal of cell biology.

[72]  T Kivioja,et al.  Insights into p53 transcriptional function via genome-wide chromatin occupancy and gene expression analysis , 2012, Cell Death and Differentiation.

[73]  W. Wong,et al.  Activation of Innate Immunity Is Required for Efficient Nuclear Reprogramming , 2012, Cell.

[74]  Harald J. Maier,et al.  Epithelial-Mesenchymal Transition in Pancreatic Carcinoma , 2010, Cancers.

[75]  Rong-Yu Liu,et al.  Imbalance in the Th17/Treg and cytokine environment in peripheral blood of patients with adenocarcinoma and squamous cell carcinoma , 2013, Medical Oncology.

[76]  S. Vlahopoulos,et al.  JNK: A Key Modulator of Intracellular Signaling , 2004, Biochemistry (Moscow).

[77]  Jung-A Choi,et al.  Ras Promotes Transforming Growth Factor-β (TGF-β)-induced Epithelial-Mesenchymal Transition via a Leukotriene B4 Receptor-2-linked Cascade in Mammary Epithelial Cells* , 2014, The Journal of Biological Chemistry.

[78]  C. Van Lint,et al.  Hyperactivated NF-κB and AP-1 Transcription Factors Promote Highly Accessible Chromatin and Constitutive Transcription across the Interleukin-6 Gene Promoter in Metastatic Breast Cancer Cells , 2009, Molecular and Cellular Biology.

[79]  H. Zeh,et al.  NF-κB hyperactivation in tumor tissues allows tumor-selective reprogramming of the chemokine microenvironment to enhance the recruitment of cytolytic T effector cells. , 2012, Cancer research.

[80]  Rosette Lidereau,et al.  BMC Cancer BioMed Central Research article NF-kappa B genes have a major role in Inflammatory Breast Cancer , 2008 .

[81]  Fotini Tzortzatou-Stathopoulou,et al.  Prednisolone exerts late mitogenic and biphasic effects on resistant acute lymphoblastic leukemia cells: Relation to early gene expression. , 2009, Leukemia research.

[82]  V. Paradis,et al.  Transcriptional profiling of pure fibrolamellar hepatocellular carcinoma reveals an endocrine signature , 2014, Hepatology.

[83]  M. Karin,et al.  IkappaB kinase alpha kinase activity is required for self-renewal of ErbB2/Her2-transformed mammary tumor-initiating cells. , 2007, Proceedings of the National Academy of Sciences of the United States of America.

[84]  C. T. Leung.  Epithelial cell translocation: New insights into mechanisms of tumor initiation , 2013, BioEssays : news and reviews in molecular, cellular and developmental biology.

[85]  M. Haymond,et al.  Hyperglycemia during induction therapy is associated with poorer survival in children with acute lymphocytic leukemia. , 2009, The Journal of pediatrics.

[86]  N. Golestaneh,et al.  STAT3 Protein Promotes T-cell Survival and Inhibits Interleukin-2 Production through Up-regulation of Class O Forkhead Transcription Factors* , 2011, The Journal of Biological Chemistry.

[87]  A. Brasier,et al.  Nuclear factor-kappaB-dependent induction of interleukin-8 gene expression by tumor necrosis factor alpha: evidence for an antioxidant sensitive activating pathway distinct from nuclear translocation. , 1999, Blood.

[88]  A. Zannettino,et al.  Tug of war in the haematopoietic stem cell niche: do myeloma plasma cells compete for the HSC niche? , 2012, Blood Cancer Journal.

[89]  S. Saccani,et al.  Modulation of NF-kappaB activity by exchange of dimers. , 2003, Molecular cell.

[90]  Wenhui Hu,et al.  NFκB signaling regulates embryonic and adult neurogenesis , 2012, Frontiers in Biology.

[91]  V. Rotter,et al.  Tumor-Promoting Circuits That Regulate a Cancer-Related Chemokine Cluster: Dominance of Inflammatory Mediators Over Oncogenic Alterations , 2012, Cancers.

[92]  G. Hajishengallis,et al.  Endogenous modulators of inflammatory cell recruitment. , 2013, Trends in immunology.

[93]  Huaxi Xu,et al.  The Th17/Treg imbalance and cytokine environment in peripheral blood of patients with rheumatoid arthritis , 2012, Rheumatology International.

[94]  Antonio Rosato,et al.  Mutant p53 reprograms TNF signaling in cancer cells through interaction with the tumor suppressor DAB2IP. , 2014, Molecular cell.

[95]  A. Knudson,et al.  Meta-Analysis Identifies NF-κB as a Therapeutic Target in Renal Cancer , 2013, PloS one.

[96]  Sumit K. Chanda,et al.  Tumor suppressor protein (p)53, is a regulator of NF-κB repression by the glucocorticoid receptor , 2011, Proceedings of the National Academy of Sciences.

[97]  M. Nieto,et al.  Inflammation and EMT: an alliance towards organ fibrosis and cancer progression , 2009, EMBO molecular medicine.

[98]  G. Chrousos,et al.  New use for old drugs? Prospective targets of chloroquines in cancer therapy. , 2014, Current drug targets.

[99]  H. Moses,et al.  Deletion of TGF‐β signaling in myeloid cells enhances their anti‐tumorigenic properties , 2012, Journal of leukocyte biology.

[100]  Alberto Mantovani,et al.  Macrophage plasticity and polarization: in vivo veritas. , 2012, The Journal of clinical investigation.

[101]  B. Aggarwal,et al.  NF-κB and cancer: how intimate is this relationship , 2010, Molecular and Cellular Biochemistry.

[102]  M. Redrado,et al.  Epithelial to mesenchymal transition and cancer stem cell phenotypes leading to liver metastasis are abrogated by the novel TGFβ1-targeting peptides P17 and P144. , 2013, Experimental cell research.

[103]  V. Fendrich,et al.  Chronic Pancreatitis and Systemic Inflammatory Response Syndrome Prevent Impact of Chemotherapy with Gemcitabine in a Genetically Engineered Mouse Model of Pancreatic Cancer , 2014, Neoplasia.

[104]  S. Balk,et al.  Targeting steroid hormone receptor pathways in the treatment of hormone dependent cancers. , 2004, Current pharmaceutical biotechnology.

[105]  M. Huang,et al.  Tumor cyclooxygenase 2-dependent suppression of dendritic cell function. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[106]  K. Iwabuchi,et al.  Dendritic cell differentiation with prostaglandin E2 results in selective attenuation of the extracellular signal‐related kinase pathway and decreased interleukin‐23 production , 2010, Immunology.

[107]  W. Frankel,et al.  Pancreatic cancer-associated stellate cells promote differentiation of myeloid-derived suppressor cells in a STAT3-dependent manner. , 2013, Cancer research.

[108]  David Haussler,et al.  ENCODE Data in the UCSC Genome Browser: year 5 update , 2012, Nucleic Acids Res..

[109]  P. Muti,et al.  SASP mediates chemoresistance and tumor-initiating-activity of mesothelioma cells , 2012, Oncogene.

[110]  R. Diaz-Avalos,et al.  Molecular Mechanism of Fascin Function in Filopodial Formation* , 2012, The Journal of Biological Chemistry.

[111]  A. Richardson,et al.  STAT3 Induction of miR-146b Forms a Feedback Loop to Inhibit the NF-κB to IL-6 Signaling Axis and STAT3-Driven Cancer Phenotypes , 2014, Science Signaling.

[112]  A. Hill,et al.  Ductal barriers in mammary epithelium , 2013, Tissue barriers.

[113]  J. Weiss,et al.  TGF-β signaling in myeloid cells is required for tumor metastasis. , 2013, Cancer discovery.

[114]  K. Khalili,et al.  Nuclear Factor Kappa B Signaling Initiates Early Differentiation of Neural Stem Cells , 2012, Stem cells.

[115]  N. Tanaka,et al.  Activated p53 induces NF-kappaB DNA binding but suppresses its transcriptional activation. , 2008, Biochemical and biophysical research communications.

[116]  B. Aggarwal,et al.  Curcumin potentiates antitumor activity of gemcitabine in an orthotopic model of pancreatic cancer through suppression of proliferation, angiogenesis, and inhibition of nuclear factor-kappaB-regulated gene products. , 2007, Cancer research.

[117]  P. Muti,et al.  Metformin elicits anticancer effects through the sequential modulation of DICER and c-MYC , 2012, Nature Communications.

[118]  S. Gerondakis,et al.  Roles of the NF-kappaB pathway in lymphocyte development and function. , 2010, Cold Spring Harbor perspectives in biology.

[119]  Hua Yu,et al.  A Requirement of STAT 3 DNA Binding Precludes Th1 Immunostimulatory Gene Expression by NFk B in Tumors , 2011 .

[120]  R. Schiffelers,et al.  Microvesicles and exosomes: opportunities for cell-derived membrane vesicles in drug delivery. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[121]  Accelerated protein evolution analysis reveals genes and pathways associated with the evolution of mammalian longevity , 2013, AGE.

[122]  Liyan Xu,et al.  GATA3 Transcription Factor Abrogates Smad4 Transcription Factor-mediated Fascin Overexpression, Invadopodium Formation, and Breast Cancer Cell Invasion* , 2013, The Journal of Biological Chemistry.

[123]  M. Ghielmini,et al.  A multicenter phase II trial (SAKK 36/06) of single-agent everolimus (RAD001) in patients with relapsed or refractory mantle cell lymphoma , 2012, Haematologica.

[124]  Wei Chen,et al.  HIF-α/MIF and NF-κB/IL-6 axes contribute to the recruitment of CD11b+Gr-1+ myeloid cells in hypoxic microenvironment of HNSCC. , 2014, Neoplasia.

[125]  I. Keklikoglou,et al.  Epigenetic Upregulation of lncRNAs at 13q14.3 in Leukemia Is Linked to the In Cis Downregulation of a Gene Cluster That Targets NF-kB , 2013, PLoS genetics.

[126]  Jun Yu,et al.  Warburg effect revisited: an epigenetic link between glycolysis and gastric carcinogenesis , 2010, Oncogene.

[127]  V. Rotter,et al.  The inflammatory cytokine TNFα cooperates with Ras in elevating metastasis and turns WT-Ras to a tumor-promoting entity in MCF-7 cells , 2014, BMC Cancer.

[128]  P. Houghton,et al.  Studies on the mechanism of resistance to rapamycin in human cancer cells. , 1998, Molecular pharmacology.

[129]  J. Cidlowski,et al.  Molecular control of immune/inflammatory responses: interactions between nuclear factor-kappa B and steroid receptor-signaling pathways. , 1999, Endocrine reviews.

[130]  George I. Lambrou,et al.  Glucocorticoid and proteasome inhibitor impact on the leukemic lymphoblast: Multiple, diverse signals converging on a few key downstream regulators , 2012, Molecular and Cellular Endocrinology.

[131]  Abhishek Mitra,et al.  A probabilistic approach to learn chromatin architecture and accurate inference of the NF-κB/RelA regulatory network using ChIP-Seq , 2013, Nucleic acids research.

[132]  Miss A.O. Penney.  (b) , 1974, The New Yale Book of Quotations.

[133]  A. Bass,et al.  Masking epistasis between MYC and TGF-β pathways in antiangiogenesis-mediated colon cancer suppression. , 2014, Journal of the National Cancer Institute.

[134]  Kaitlyn N. Lewis,et al.  Stress Resistance in the Naked Mole-Rat: The Bare Essentials – A Mini-Review , 2012, Gerontology.

[135]  B. Bonavida.  RKIP-mediated chemo-immunosensitization of resistant cancer cells via disruption of the NF-κB/Snail/YY1/RKIP resistance-driver loop. , 2014, Critical reviews in oncogenesis.

[136]  D. Thanos,et al.  Epigenetic determination of a cell‐specific gene expression program by ATF‐2 and the histone variant macroH2A , 2006, The EMBO journal.

[137]  P. McCrea,et al.  Glucocorticoid Down-regulation of Fascin Protein Expression Is Required for the Steroid-induced Formation of Tight Junctions and Cell-Cell Interactions in Rat Mammary Epithelial Tumor Cells* , 1999, The Journal of Biological Chemistry.

[138]  Nicolai J. Birkbak,et al.  Clonal status of actionable driver events and the timing of mutational processes in cancer evolution , 2015, Science Translational Medicine.

[139]  H. Aburatani,et al.  The Role of NF-κB Signaling in the Maintenance of Pluripotency of Human Induced Pluripotent Stem Cells , 2013, PloS one.

[140]  Hua Yu,et al.  A requirement of STAT3 DNA binding precludes Th-1 immunostimulatory gene expression by NF-κB in tumors. , 2011, Cancer research.

[141]  Allan R. Brasier,et al.  Tumor Necrosis Factor-α-inducible IκBα Proteolysis Mediated by Cytosolic m-Calpain , 1999, The Journal of Biological Chemistry.

[142]  N. Perkins,et al.  The role of RelA (p65) threonine 505 phosphorylation in the regulation of cell growth, survival, and migration , 2011, Molecular biology of the cell.

[143]  M. Karin,et al.  Dangerous liaisons: STAT3 and NF-kappaB collaboration and crosstalk in cancer. , 2010, Cytokine & growth factor reviews.

[144]  W. Evans,et al.  Inhibition of glycolysis modulates prednisolone resistance in acute lymphoblastic leukemia cells. , 2009, Blood.

[145]  Hyoju Yi,et al.  Metformin downregulates Th17 cells differentiation and attenuates murine autoimmune arthritis. , 2013, International immunopharmacology.

[146]  yang-xin fu,et al.  Targeting tumors with LIGHT to generate metastasis-clearing immunity. , 2008, Cytokine & growth factor reviews.

[147]  T. Hei,et al.  Sodium arsenite exposure inhibits AKT and Stat3 activation, suppresses self-renewal and induces apoptotic death of embryonic stem cells , 2013, Apoptosis.

[148]  M. Lako,et al.  Opposing Putative Roles for Canonical and Noncanonical NFκB Signaling on the Survival, Proliferation, and Differentiation Potential of Human Embryonic Stem Cells , 2010, Stem cells.

[149]  C. Thiele,et al.  Inhibition of STAT3 with orally active JAK inhibitor, AZD1480, decreases tumor growth in Neuroblastoma and Pediatric Sarcomas In vitro and In vivo , 2013, Oncotarget.

[150]  B. Aggarwal,et al.  Signal Transducer and Activator of Transcription‐3, Inflammation, and Cancer , 2009, Annals of the New York Academy of Sciences.

[151]  Clyde J. Wright,et al.  Nuclear Factor-κB (NF-κB) Inhibitory Protein IκBβ Determines Apoptotic Cell Death following Exposure to Oxidative Stress* , 2012, The Journal of Biological Chemistry.

[152]  J. Slaton.  Small molecules that reactivate p53 in renal cell carcinoma reveal a NF-kappaB-dependent mechanism of p53 suppression in tumors , 2006 .

[153]  I. Kondakova,et al.  Expression of vascular endothelial growth factor and transcription factors HIF-1, NF-kB expression in squamous cell carcinoma of head and neck; association with proteasome and calpain activities , 2013, Journal of Cancer Research and Clinical Oncology.

[154]  J. Vose,et al.  Novel Treatment for Mantle Cell Lymphoma Including Therapy-Resistant Tumor by NF-κB and mTOR Dual-Targeting Approach , 2013, Molecular Cancer Therapeutics.

[155]  Gerald C. Chu,et al.  PTEN is a major tumor suppressor in pancreatic ductal adenocarcinoma and regulates an NF-κB-cytokine network. , 2011, Cancer discovery.

[156]  H. Xin,et al.  Correction: A requirement of STAT3 DNA binding precludes Th-1 immunostimulatory gene expression by NF-κB in tumors (Cancer Research (2011) 71, (3772-3880)) , 2011 .

[157]  J. Brady,et al.  A novel NF-kappaB pathway involving IKKbeta and p65/RelA Ser-536 phosphorylation results in p53 Inhibition in the absence of NF-kappaB transcriptional activity. , 2005, The Journal of biological chemistry.